[1] R. Kamps, R. D. Brandão, B. J. van den Bosch. Next-generation sequencing in oncology: genetic diagnosis, risk prediction and cancer classification. Int. J. Mol. Sci., 18, 308(2017).

[2] N. D. Ferrante, A. Pillai, A. G. Singal. Update on the diagnosis and treatment of hepatocellular carcinoma. J. Gastroenterol. Hepatol., 16, 506(2020).

[3] M. Omata, A. Cheng, N. Kokudo. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int., 11, 317-370(2017).

[4] G. P. Caviglia, D. G. Ribaldone, M. L. Abate. Performance of protein induced by vitamin K absence or antagonist-II assessed by chemiluminescence enzyme immunoassay for hepatocellular carcinoma detection: a meta-analysis. Scand. J. Gastroenterol., 53, 734-740(2018).

[5] J. Zong, Z. Fan, Y. Zhang. Serum tumor markers for early diagnosis of primary hepatocellular carcinoma. J. Hepatocell. Carcinoma, 413-422(2020).

[6] R. Yu, Z. Tan, X. Xiang. Effectiveness of PIVKA-II in the detection of hepatocellular carcinoma based on real-world clinical data. BMC Cancer, 17(2017).

[7] H. A. Liebman, B. C. Furie, M. J. Tong. Des-γ-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. N. Engl. J. Med., 310, 1427-1431(1984).

[8] F. Piñero, M. Dirchwolf, M. G. Pessôa. Biomarkers in hepatocellular carcinoma: diagnosis, prognosis and treatment response assessment. Cells, 9, 1370(2020).

[9] E. Degasperi, R. Perbellini, R. D’Ambrosio. Prothrombin induced by vitamin K absence or antagonist-II and alpha foetoprotein to predict development of hepatocellular carcinoma in Caucasian patients with hepatitis C-related cirrhosis treated with direct-acting antiviral agents. Aliment. Pharmacol. Ther., 55, 350-359(2022).

[10] G. Ricco, C. Cosma, G. Bedogni. Modeling the time-related fluctuations of AFP and PIVKA-II serum levels in patients with cirrhosis undergoing surveillance for hepatocellular carcinoma. Cancer Biomark., 29, 189-196(2020).

[11] H. So, S. Angupillai, Y. Son. Prompt liquid-phase visual detection and low-cost vapor-phase detection of DCP, a chemical warfare agent mimic. Sens. Actuators B Chem., 235, 447-456(2016).

[12] X. Liu, R. Singh, M. Li. Plasmonic sensor based on offset-splicing and waist-expanded taper using multicore fiber for detection of Aflatoxins B1 in critical sectors. Opt. Express, 31, 4783-4802(2023).

[13] S. Zhu, Z. Xie, Y. Chen. Real-time detection of circulating tumor cells in bloodstream using plasmonic fiber sensors. Biosensors, 12, 968(2022).

[14] X. Chen, X. Li, D. Yi. Plasmonic tapered-fiber interference sensor for simultaneously detecting refractive index and temperature. Opt. Lett., 46, 6071-6074(2021).

[15] M. Sypabekova, A. Amantayeva, L. Vangelista. Ultralow limit detection of soluble HER2 biomarker in serum with a fiber-optic ball-tip resonator assisted by a tilted FBG. ACS Meas. Sci. Au, 2, 309-316(2022).

[16] W. Zhang, R. Singh, Z. Wang. Humanoid shaped optical fiber plasmon biosensor functionalized with graphene oxide/multi-walled carbon nanotubes for histamine detection. Opt. Express, 31, 11788-11803(2023).

[17] G. Li, X. Li, R. Singh. Slide-type waveflex biosensor based on signal enhancement technology for alpha-fetoprotein detection. Opt. Lett., 48, 4745-4748(2023).

[18] J. Zhao, Y. Zhao, R.-Q. Lv. A fiber ring cavity laser temperature sensor based on polymer-coated no-core fiber as tunable filter. IEEE Trans. Instrum. Meas., 70, 9513609(2021).

[19] X. Hu, Y. Zhao, Y. Peng. In-fiber optofluidic Michelson interferometer for detecting small volume and low concentration chemicals with a fiber ring cavity laser. Sens. Actuators B Chem., 370, 132467(2022).

[20] L. Chen, Y. Leng, S. Qiu. Ultrahigh-sensitivity label-free singlemode-tapered no core-singlemode fiber immunosensor for Listeria monocytogenes detection. Sens. Actuators B Chem., 376, 132930(2023).

[21] J. Tai, S. Fan, S. Ding. Gold nanoparticles based optical biosensors for cancer biomarker proteins: a review of the current practices. Front. Bioeng. Biotechnol., 10, 877193(2022).

[22] J. K. Virk, S. Das, R. Kaler. D-shape optical fiber probe dimension optimization for LSPR based bio-sensor. Opt. Fiber Technol., 71, 102930(2022).

[23] R. Singh, W. Zhang, X. Liu. WaveFlex biosensor: MXene-immobilized W-shaped fiber-based LSPR sensor for highly selective tyramine detection. Opt. Laser Technol., 171, 110357(2024).

[24] V. G. Das. Q-switched Er-doped fiber laser using an aqueous solution of gold nanorods and polyvinyl alcohol. Opt. Fiber Technol., 83, 103672(2024).

[25] C. Chen, J. Wang. Optical biosensors: an exhaustive and comprehensive review. Analyst, 145, 1605-1628(2020).

[26] G. Li, R. Singh, J. Guo. Nb₂CT_x MXene-assisted double S-tapered fiber-based LSPR sensor with improved features for tyramine detection. Appl. Phys. Lett., 122, 083701(2023).

[27] I. M. White, X. Fan. On the performance quantification of resonant refractive index sensors. Opt. Express, 16, 1020-1028(2008).

[28] S. Kumar, Z. Guo, R. Singh. MoS₂ functionalized multicore fiber probes for selective detection of Shigella bacteria based on localized plasmon. J. Lightwave Technol., 39, 4069-4081(2021).

[29] A. Sohn, H. Kim, S. J. Yu. A quantitative analytical method for PIVKA-II using multiple reaction monitoring-mass spectrometry for early diagnosis of hepatocellular carcinoma. Anal. Bioanal. Chem., 409, 2829-2838(2017).

[30] S. G. Zhang, Y. Huang. Usefulness of AFP, PIVKA-II, and their combination in diagnosing hepatocellular carcinoma based on upconversion luminescence immunochromatography. J. Lab. Med., 53, 488-494(2022).

[31] K. Fujita, H. Kinukawa, K. Ohno. Development and evaluation of analytical performance of a fully automated chemiluminescent immunoassay for protein induced by vitamin K absence or antagonist II. Clin. Biochem., 48, 1330-1336(2015).

[32] H. Okuda. Measurement of serum levels of des-γ-carboxy prothrombin in patients with hepatocellular carcinoma by a revised enzyme immunoassay kit with increased sensitivity. Cancer, 82, 1643-1648(1998).